Sequential determination of viral load, humoral responses and phylogenetic analysis in fatal and non-fatal cases of Crimean-Congo hemorrhagic fever patients from Gujarat, India, 2019.
Adolescent
Adult
Aged
Animals
Antibodies, Viral
/ blood
Cytokines
/ blood
Female
Genotype
Hemorrhagic Fever Virus, Crimean-Congo
/ classification
Hemorrhagic Fever, Crimean
/ blood
Humans
Immunity, Humoral
India
/ epidemiology
Livestock
/ blood
Male
Middle Aged
Phylogeny
RNA, Viral
/ genetics
Ticks
/ virology
Viral Load
Young Adult
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
04
01
2021
accepted:
08
08
2021
revised:
10
09
2021
pubmed:
31
8
2021
medline:
26
11
2021
entrez:
30
8
2021
Statut:
epublish
Résumé
Thirty-four CCHF cases (17 fatal; 17 survived) were confirmed from Gujarat state, India during the year 2019. We aimed to find out the viral load, antibody kinetics, cytokine profile and phylogenetic analysis between fatal and non- fatal cases. Thirty four cases were included in this study. Blood and urine samples were collected from all the cases on the day of admission to hospital. Non-fatal cases were followed weekly for understanding the profile of viral kinetics, anti-CCHFV IgM and IgG antibodies. We also quantified the cytokines in both fatal and non-fatal cases. For epidemiological correlation, livestock were screened for anti-CCHF IgG antibodies and the tick pool specimens were tested by real time RT-PCR. Virus isolation was attempted on tick pools and human specimens and phylogenetic analysis performed on human and ticks complete genome sequences. CCHF cases were detected throughout year in 2019 with the peak in August. Out of 34 cases, eight secondary CCHF cases were reported. Cases were predominantly detected in males and in 19-45 years age group (55.88%). The persistence of viremia was observed till 76th POD (post onset date) in one case whereas anti-CCHFV IgM and IgG was detected amongst these cases from the 2nd and 20th POD respectively. Positivity observed amongst livestock and tick pools were was 21.57% and 7.4% respectively. The cytokine analysis revealed a significant increase in the level of serum IL-6, IL-10 and IFN-γ during the acute phase of the infection, but interestingly IL-10 lowered to normal upon clearance of the virus in the clinically recovered case. Fatal cases had high viral RNA copy numbers. Bleeding from one or two mucosal sites was significantly associated with fatality (OR-16.47;p-0.0034 at 95% CI). We could do CCHF virus isolation from two cases. Phylogenetic analysis revealed circulation of re-assortment of Asian-West African genotypes in humans and ticks. The persistence of CCHF viral RNA was detected till 76th POD in one of the survivors. The circulation of a re-assortment Asian-West African genotype in a CCHF case is also reported first time from India.
Sections du résumé
BACKGROUND
Thirty-four CCHF cases (17 fatal; 17 survived) were confirmed from Gujarat state, India during the year 2019. We aimed to find out the viral load, antibody kinetics, cytokine profile and phylogenetic analysis between fatal and non- fatal cases.
METHODS
Thirty four cases were included in this study. Blood and urine samples were collected from all the cases on the day of admission to hospital. Non-fatal cases were followed weekly for understanding the profile of viral kinetics, anti-CCHFV IgM and IgG antibodies. We also quantified the cytokines in both fatal and non-fatal cases. For epidemiological correlation, livestock were screened for anti-CCHF IgG antibodies and the tick pool specimens were tested by real time RT-PCR. Virus isolation was attempted on tick pools and human specimens and phylogenetic analysis performed on human and ticks complete genome sequences.
RESULTS
CCHF cases were detected throughout year in 2019 with the peak in August. Out of 34 cases, eight secondary CCHF cases were reported. Cases were predominantly detected in males and in 19-45 years age group (55.88%). The persistence of viremia was observed till 76th POD (post onset date) in one case whereas anti-CCHFV IgM and IgG was detected amongst these cases from the 2nd and 20th POD respectively. Positivity observed amongst livestock and tick pools were was 21.57% and 7.4% respectively. The cytokine analysis revealed a significant increase in the level of serum IL-6, IL-10 and IFN-γ during the acute phase of the infection, but interestingly IL-10 lowered to normal upon clearance of the virus in the clinically recovered case. Fatal cases had high viral RNA copy numbers. Bleeding from one or two mucosal sites was significantly associated with fatality (OR-16.47;p-0.0034 at 95% CI). We could do CCHF virus isolation from two cases. Phylogenetic analysis revealed circulation of re-assortment of Asian-West African genotypes in humans and ticks.
CONCLUSIONS
The persistence of CCHF viral RNA was detected till 76th POD in one of the survivors. The circulation of a re-assortment Asian-West African genotype in a CCHF case is also reported first time from India.
Identifiants
pubmed: 34460819
doi: 10.1371/journal.pntd.0009718
pii: PNTD-D-20-02245
pmc: PMC8432894
doi:
Substances chimiques
Antibodies, Viral
0
Cytokines
0
RNA, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0009718Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Jpn J Infect Dis. 2009 Jan;62(1):11-5
pubmed: 19168952
Lancet Infect Dis. 2006 Apr;6(4):203-14
pubmed: 16554245
Biomed Rep. 2016 Jan;4(1):15-20
pubmed: 26870327
Clin Vaccine Immunol. 2010 Jul;17(7):1086-93
pubmed: 20484568
Vector Borne Zoonotic Dis. 2012 Sep;12(9):812-6
pubmed: 22007611
BMC Infect Dis. 2014 Jul 28;14:416
pubmed: 25066751
Emerg Infect Dis. 2017 Jun;23(6):1005-1008
pubmed: 28518037
J Clin Microbiol. 2016 Jan;54(1):49-58
pubmed: 26491176
Int J Clin Exp Med. 2014 Mar 15;7(3):751-7
pubmed: 24753773
Antiviral Res. 2016 Feb;126:21-34
pubmed: 26695860
Clin Infect Dis. 2007 Oct 1;45(7):e96-100
pubmed: 17806044
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183931
BMC Infect Dis. 2019 Feb 1;19(1):104
pubmed: 30709372
PLoS Negl Trop Dis. 2020 Jun 29;14(6):e0008238
pubmed: 32598383
Cytokine. 2004 Sep 21;27(6):173-9
pubmed: 15304247
J Infect. 2009 Mar;58(3):238-44
pubmed: 19246100
Emerg Infect Dis. 2018 May;24(5):898-901
pubmed: 29664366
J Med Virol. 2017 Oct;89(10):1707-1713
pubmed: 28547808
PLoS Negl Trop Dis. 2012;6(5):e1653
pubmed: 22616022
Int J Infect Dis. 2017 May;58:82-89
pubmed: 28259724
J Clin Virol. 2006 Aug;36(4):272-6
pubmed: 16765637
Emerg Infect Dis. 2007 Jul;13(7):1097-100
pubmed: 18214191
Emerg Infect Dis. 2009 Mar;15(3):461-4
pubmed: 19239765
S Afr Med J. 1985 Nov 9;68(10):722-8
pubmed: 3933128
Virus Res. 2020 Sep;286:198046
pubmed: 32505728
J Infect Dis. 2006 Apr 1;193(7):941-4
pubmed: 16518755
Indian J Med Res. 2015 Oct;142(4):489-91
pubmed: 26609042
Emerg Infect Dis. 2007 Nov;13(11):1769-72
pubmed: 18217568